UROY (UROY) Stock Price & Analysis
UROY (UROY) fell 4.52% to USD 2.96 as of July 25, 2026 at 04:14 UTC, according to Nexqual real-time market data.
UROY last closed at USD 3.1; the session ranged USD 2.88–3.07 on volume of 4,100,660 shares. Market capitalization is $433.91M, with a 52-week range of USD 2.42–5.52 (NCM). Source: Nexqual, July 25, 2026 at 04:14 UTC.
Key Statistics (as of July 25, 2026 at 04:14 UTC)
| Price | USD 2.96 |
|---|---|
| Change | ▼ 4.52% (down) |
| Previous Close | USD 3.1 |
| Open | USD 3.07 |
| Day Range | USD 2.88 – 3.07 |
| 52-Week Range | USD 2.42 – 5.52 |
| Volume | 4,100,660 shares |
| Market Cap | $433.91M |
| Exchange | NCM |
Technical Analysis (UROY)
Nexqual's technical model rates UROY "NEUTRAL" based on 2 bullish and 3 bearish signals across 125 daily candles, as of July 25, 2026 at 04:14 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 53.33 (neutral) |
| vs SMA50 | Below (USD 3.1) |
| MACD | -0.03 (negative) |
Analyst Ratings (UROY)
Wall Street analysts rate UROY "Strong Buy" based on 1 analysts, with a mean price target of USD 4.49 (range USD 4.49–4.49), per Nexqual as of July 25, 2026 at 04:14 UTC.
| Consensus Rating | Strong Buy |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 4.49 |
| High Target | USD 4.49 |
| Low Target | USD 4.49 |
| Buy / Hold / Sell | 4 / 0 / 0 |
Earnings (UROY)
| Next Earnings Date | 2026-07-28 |
|---|---|
| EPS Estimate | USD -0.01 |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-01-31 | USD 0.01 vs est -0.01 ▲ beat |
| 2025-10-31 | USD 0.02 vs est -0.01 ▲ beat |
| 2025-07-31 | USD 0.01 vs est -0.01 ▲ beat |
| 2025-04-30 | USD -0.01 vs est -0.01 ▲ beat |
Source: Nexqual, July 25, 2026 at 04:14 UTC.
Financials & Fundamentals (UROY)
| Total Revenue | $54.60M |
|---|---|
| Revenue Growth (YoY) | +416400.00% |
| Gross Margin | +19.91% |
| Operating Margin | +17.77% |
| Profit Margin | +8.03% |
| ROE | +1.29% |
| Debt / Equity | 0.04 |
| Current Ratio | 325.28 |
| Total Cash | $138.77M |
| Total Debt | $168,000 |
| Free Cash Flow | $37.97M |
Source: Nexqual, July 25, 2026 at 04:14 UTC.
Financial Health Score (UROY)
Nexqual rates UROY's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 04:14 UTC.
| Growth | Critical — Revenue -64% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Small revenue base — building scale |
| Balance Sheet | Strong — $139M cash, no debt |
| Cash Flow | Strong — FCF $38M, 245% margin |
| Efficiency | Weak — ROE 1%, ROA 0.4% |
Ownership (UROY)
| Insider Ownership | +14.37% |
|---|---|
| Institutional Ownership | +32.53% |
| Shares Outstanding | 146.59M |
| Float | 125.28M |
Source: Nexqual, July 25, 2026 at 04:14 UTC.
Leadership (UROY)
UROY is led by Scott Eric Melbye (age 63), CEO, President & Director, per Nexqual as of July 25, 2026 at 04:14 UTC.
| CEO, President & Director | Scott Eric Melbye (age 63) |
|---|---|
| Chief Financial Officer | Andrew Marshall BA(Hons), C.A., C.F.A. (age 45) |
Major Backers & Investors (UROY)
Notable institutional backers of UROY include SPROTT FUNDS TRUST-SPROTT URANIUM MINERS ETF, Mirae Asset Global ETFs Holdings Ltd., GLOBAL X FUNDS-Global X Uranium ETF, according to Nexqual as of July 25, 2026 at 04:14 UTC.
Active Investors
| Investor | Stake |
|---|---|
| SPROTT FUNDS TRUST-SPROTT URANIUM MINERS ETF | 6.32% |
| Mirae Asset Global ETFs Holdings Ltd. | 6.07% |
| GLOBAL X FUNDS-Global X Uranium ETF | 5.18% |
| Alps Advisors Inc. | 2.85% |
| CenterBook Partners LP | 2.41% |
| Morgan Stanley | 2.11% |
| Accordant Advisory Group Inc | 1.71% |
| BNP Paribas Financial Markets | 1.37% |
Source: Nexqual, July 25, 2026 at 04:14 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| NXE | Nexgen Energy Ltd. | USD 9.14 | ▼ 3.18% |
| URG | Ur Energy Inc | USD 1.22 | ▼ 6.15% |
| GROY | Gold Royalty Corp. | USD 2.57 | ▼ 2.65% |
| SRUUF | Sprott Physical Uranium Trust | USD 18.82 | ▲ 0.43% |
| UEC | Uranium Energy Corp. | USD 9.51 | ▼ 2.26% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:14 UTC. This page is informational and not investment advice.